Algo version: 0.98b
Zhejiang Medicine Co., is listed at the SHH Exchange
Zhejiang Medicine Co., [600216.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Zhejiang Medicine Co., stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Zhejiang Medicine Co., pays dividends. Last time was Wednesday 10th of July 2024 where the investors holding the stock on Wednesday 10th of July 2024 were paid CNY0.15 per share. Over the last 22 times between 2000 and 2024, Zhejiang Medicine Co., has paid CNY6.0809 with an average of CNY0.28 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Zhejiang Medicine Co., 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY12.97, you would have made a profit of CNY1.550 per share or 11.95%

Yes, the average daily trading liquidity for Zhejiang Medicine Co., is CNY39.63 million. You should therefore be able to get in and out of your positions relatively fast.

Zhejiang Medicine Co., has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.75, the company's ability to pay off the debt is good. Zhejiang Medicine Co., has a good net profit margin of 5.30% and should have high tolerances against inflation.

We have calculated the inflation risk for Zhejiang Medicine Co., to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.